Brainstorm Cell Therapeutics (BCLI) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free BCLI Stock Alerts $0.58 +0.01 (+1.05%) (As of 04:28 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Brainstorm Cell Therapeutics Short Interest DataCurrent Short Interest2,100,000 sharesPrevious Short Interest1,990,000 sharesChange Vs. Previous Month+5.53%Dollar Volume Sold Short$792,750.00Short Interest Ratio2.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares70,080,000 sharesPercentage of Shares Shorted3.00%Today's Trading Volume396,422 sharesAverage Trading Volume934,862 sharesToday's Volume Vs. Average42% Short Selling Brainstorm Cell Therapeutics ? Sign up to receive the latest short interest report for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCLI Short Interest Over TimeBCLI Days to Cover Over TimeBCLI Percentage of Float Shorted Over Time Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion Superproject?Nvidia recently added $277 billion in market cap … IN ONE DAY.Find out details on these three critical Nvidia partners immediately. Brainstorm Cell Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,100,000 shares $792,750.00 +5.5%N/A2.1 $0.38 4/15/20241,990,000 shares $1.09 million +48.5%N/A2 $0.55 3/31/20241,340,000 shares $756,698.00 +57.6%N/A1.3 $0.56 3/15/2024850,300 shares $283,064.87 -20.5%N/A0.6 $0.33 2/29/20241,070,000 shares $392,690.00 -13.0%N/A0.7 $0.37 2/15/20241,230,000 shares $477,240.00 -39.4%N/A0.5 $0.39 Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,030,000 shares $717,199.00 -15.1%N/A0.8 $0.35 1/15/20242,390,000 shares $781,291.00 -43.2%N/A0.9 $0.33 12/31/20234,210,000 shares $1.15 million +25.3%N/A1.5 $0.27 12/15/20233,360,000 shares $789,600.00 -4.0%N/A0.9 $0.24 11/30/20233,500,000 shares $976,500.00 -7.2%N/A1.1 $0.28 11/15/20233,770,000 shares $689,910.00 +5.6%N/A1.6 $0.18 10/31/20233,570,000 shares $546,210.00 -20.5%9.8%1.9 $0.15 10/15/20234,490,000 shares $763,300.00 +1.1%12.4%2.6 $0.17 9/30/20234,440,000 shares $888,444.00 +26.1%12.2%3 $0.20 9/15/20233,520,000 shares $3.39 million +9.3%9.7%9.3 $0.96 8/31/20233,220,000 shares $5.51 million +21.1%9.2%13.4 $1.71 8/15/20232,660,000 shares $4.15 million No Change7.6%11.3 $1.56 7/31/20232,660,000 shares $4.89 million -5.3%8.6%12 $1.84 7/15/20232,810,000 shares $5.54 million +0.4%9.1%12.1 $1.97 6/30/20232,800,000 shares $5.77 million +2.9%9.1%11.7 $2.06 6/15/20232,720,000 shares $7.37 million -5.6%8.8%6.7 $2.71 5/31/20232,880,000 shares $8.21 million +0.4%9.6%7.2 $2.85 5/15/20232,870,000 shares $7.92 million -9.2%9.5%8 $2.76 4/30/20233,160,000 shares $9.13 million +7.9%11.3%7.8 $2.89 4/15/20232,930,000 shares $8.23 million -5.5%10.4%7.3 $2.81 3/31/20233,100,000 shares $10.23 million +29.7%11.0%7.7 $3.30 3/15/20232,390,000 shares $3.87 million +0.8%8.5%10.2 $1.62 2/28/20232,370,000 shares $5.36 million +3.0%8.4%10.6 $2.26 2/15/20232,300,000 shares $5.24 million +18.6%8.1%9.6 $2.28 1/31/20231,940,000 shares $3.53 million -1.5%6.9%7 $1.82 1/15/20231,970,000 shares $2.88 million -3.9%7.0%8.3 $1.46 12/30/20222,050,000 shares $3.36 million -9.3%7.3%8.9 $1.64 12/15/20222,260,000 shares $4.09 million No Change8.0%9.6 $1.81 11/30/20222,260,000 shares $3.73 million -12.4%8.0%8.8 $1.65 11/15/20222,580,000 shares $4.46 million -4.1%9.1%9.8 $1.73 10/31/20222,690,000 shares $9.58 million +10.3%9.5%11.1 $3.56 10/15/20222,440,000 shares $8.49 million +23.2%8.7%10.2 $3.48 9/30/20221,980,000 shares $8.75 million +52.3%7.0%8.9 $4.42 9/15/20221,300,000 shares $5.59 million +68.2%4.6%7.2 $4.30The Presidential candidate you should REALLY be worried about (Ad)The Presidential candidate you should REALLY be worried about Most Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started.Get the full story right here. 8/31/2022772,900 shares $2.80 million +36.6%2.7%5.3 $3.62 8/15/2022565,900 shares $1.95 million -5.4%2.0%4.8 $3.45 7/31/2022598,200 shares $1.53 million +3.1%2.1%9.8 $2.56 7/15/2022580,300 shares $1.53 million -9.5%3.2%9.5 $2.64 6/30/2022641,300 shares $1.77 million -0.1%3.6%10.7 $2.76 6/15/2022642,100 shares $1.83 million -4.9%3.6%10.2 $2.85 5/31/2022675,200 shares $1.99 million +5.6%2.4%10.6 $2.94 5/15/2022639,600 shares $1.74 million +6.6%2.3%9.7 $2.72 4/30/2022600,200 shares $1.80 million -2.1%2.1%9.1 $3.00 4/15/2022612,800 shares $1.93 million -8.5%2.2%8.6 $3.15 3/31/2022669,400 shares $2.25 million -8.4%2.4%8.4 $3.36 3/15/2022731,100 shares $2.30 million -0.6%2.6%5.1 $3.15 2/28/2022735,200 shares $2.24 million -7.0%2.6%2.4 $3.05 2/15/2022790,200 shares $2.47 million -22.5%2.8%2.1 $3.12 1/31/20221,020,000 shares $3.18 million -9.7%3.3%2.5 $3.12 1/15/20221,130,000 shares $4.01 million -17.5%3.6%2.7 $3.55 12/31/20211,370,000 shares $5.48 million +11.4%4.4%3.3 $4.00 12/15/20211,230,000 shares $4.05 million +32.1%3.9%3.3 $3.29 11/30/2021931,500 shares $3.54 million +27.1%3.1%4.2 $3.80 11/15/2021732,900 shares $2.23 million -1.4%2.4%4.8 $3.04 10/29/2021743,600 shares $2.16 million -11.5%2.5%6.3 $2.90 10/15/2021839,800 shares $2.59 million -14.4%2.8%5.9 $3.08 9/30/2021981,000 shares $3.24 million +6.8%3.3%6.6 $3.30 9/15/2021918,700 shares $3.24 million -11.7%3.1%4.1 $3.53 8/31/20211,040,000 shares $3.61 million No Change3.5%4.3 $3.47 8/13/20211,040,000 shares $3.83 million +16.3%3.5%3.5 $3.68 7/30/2021894,200 shares $3.60 million -32.3%3.0%2.7 $4.03 7/15/20211,320,000 shares $4.51 million -5.7%4.4%3.6 $3.42 6/30/20211,400,000 shares $5.32 million -60.9%4.7%3.4 $3.80 6/15/20213,580,000 shares $14.21 million +0.3%11.9%6.3 $3.97 5/28/20213,570,000 shares $12.78 million -18.5%11.9%5.8 $3.58 5/14/20214,380,000 shares $14.10 million +14.7%N/A6 $3.22 4/30/20213,820,000 shares $13.41 million +4.1%N/A4.4 $3.51 4/15/20213,670,000 shares $12.92 million -16.4%N/A3.2 $3.52 3/31/20214,390,000 shares $16.29 million +4.0%N/A3.8 $3.71 3/15/20214,220,000 shares $18.06 million +7.4%N/A3.5 $4.28 2/26/20213,930,000 shares $15.60 million -6.9%N/A3.4 $3.97 2/12/20214,220,000 shares $30.00 million -9.4%N/A3.2 $7.11 1/29/20214,660,000 shares $29.38 million -2.9%N/A3.1 $6.31 1/15/20214,800,000 shares $24.05 million -11.1%N/A3.6 $5.01 12/31/20205,400,000 shares $25.00 million -15.2%N/A4.1 $4.63 12/15/20206,370,000 shares $33.06 million -5.9%N/A4.9 $5.19 11/30/20206,770,000 shares $35.54 million +5.5%N/A5.7 $5.25 11/15/20206,420,000 shares $74.79 million +7.5%N/A6.1 $11.65 10/30/20205,970,000 shares $64.18 million +17.5%N/A10.2 $10.75 10/15/20205,080,000 shares $84.79 million +12.1%N/A8.4 $16.69 9/30/20204,530,000 shares $76.65 million +18.3%N/A8.7 $16.92 9/15/20203,830,000 shares $54.19 million -1.5%N/A6 $14.15 8/31/20203,890,000 shares $49.05 million +8.1%N/A5.5 $12.61 8/14/20203,600,000 shares $47.77 million +2.9%N/A4.8 $13.27The Presidential candidate you should REALLY be worried about (Ad)The Presidential candidate you should REALLY be worried about Most Americans are overlooking the seemingly impossible candidate that should worry you. It's not Biden… Trump… Newsom… or even Michelle. It's someone even worse. New evidence of a secret plan indicates he could soon return, and finish what he started.Get the full story right here. 7/31/20203,500,000 shares $47.43 million -20.8%N/A4.8 $13.55 7/15/20204,420,000 shares $57.15 million No ChangeN/A6.3 $12.93 6/30/20204,420,000 shares $49.02 million +39.9%N/A7 $11.09 6/15/20203,160,000 shares $31.41 million +12.1%N/A5.8 $9.94 5/29/20202,820,000 shares $18.78 million -4.4%N/A5.2 $6.66 5/15/20202,950,000 shares $16.37 million +12.2%N/A4.7 $5.55 4/30/20202,630,000 shares $16.38 million +14.9%N/A3.2 $6.23 4/15/20202,290,000 shares $12.89 million +22.5%10.8%3 $5.63 3/31/20201,870,000 shares $11.35 million +69.5%8.8%2.6 $6.07 3/13/20201,103,400 shares $5.62 million +3.1%5.9%1.9 $5.09 2/28/20201,070,000 shares $4.94 million +40.8%5.8%2 $4.62 2/14/2020759,900 shares $5.65 million +4.8%4.1%1.7 $7.44 1/31/2020725,000 shares $5.30 million -12.5%3.9%5.1 $7.31 1/15/2020828,200 shares $3.87 million +11.7%4.4%7.7 $4.67 12/31/2019741,600 shares $3.07 million +1.8%4.0%7.5 $4.14 BCLI Short Interest - Frequently Asked Questions What is Brainstorm Cell Therapeutics' current short interest? Short interest is the volume of Brainstorm Cell Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,100,000 shares of BCLI short. Learn More on Brainstorm Cell Therapeutics' current short interest. What is a good short interest ratio for Brainstorm Cell Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCLI shares currently have a short interest ratio of 2.0. Learn More on Brainstorm Cell Therapeutics's short interest ratio. Which institutional investors are shorting Brainstorm Cell Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Brainstorm Cell Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Brainstorm Cell Therapeutics' short interest increasing or decreasing? Brainstorm Cell Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,100,000 shares, an increase of 5.5% from the previous total of 1,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Brainstorm Cell Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Brainstorm Cell Therapeutics: Lipocine Inc. (3.49%), LianBio (0.36%), SAB Biotherapeutics, Inc. (0.30%), Acasti Pharma Inc. (0.02%), AVROBIO, Inc. (0.42%), Champions Oncology, Inc. (0.95%), Alaunos Therapeutics, Inc. (9.57%), Assembly Biosciences, Inc. (0.68%), vTv Therapeutics Inc. (3.18%), BeyondSpring Inc. (9.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Brainstorm Cell Therapeutics stock? Short selling BCLI is an investing strategy that aims to generate trading profit from Brainstorm Cell Therapeutics as its price is falling. BCLI shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Brainstorm Cell Therapeutics? A short squeeze for Brainstorm Cell Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCLI, which in turn drives the price of the stock up even further. How often is Brainstorm Cell Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCLI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Lipocine Short Interest Data LianBio Short Interest Data SAB Biotherapeutics Short Interest Data Acasti Pharma Short Interest Data AVROBIO Short Interest Data Champions Oncology Short Interest Data Alaunos Therapeutics Short Interest Data Assembly Biosciences Short Interest Data vTv Therapeutics Short Interest Data BeyondSpring Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCLI) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThis could mean the end of the U.S dollar…Colonial MetalsThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeNew Options need New Trading StrategiesNetpicks